Mast Cells in Early Rheumatoid Arthritis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Apr 2019
Historique:
received: 04 04 2019
revised: 18 04 2019
accepted: 22 04 2019
entrez: 28 4 2019
pubmed: 28 4 2019
medline: 14 8 2019
Statut: epublish

Résumé

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by inflammation of the synovial membrane, with thickening of the synovial layer, cellular hyperplasia, and infiltration of immune cells. Mast cells (MCs) are cells of the innate immunity present in healthy synovia and part of the cellular hyperplasia characterizing RA synovitis. Although their presence in synovia has been well described, the exact functions and the correlation of MCs with disease development and progression have been debated, particularly because of contradictory data obtained in animal models and from patients with longstanding disease. Here, we present a revision of the literature on MCs in RA, including the most recent observations obtained from patients with early RA, indicating MCs as relevant markers of disease severity in early RA.

Identifiants

pubmed: 31027208
pii: ijms20082040
doi: 10.3390/ijms20082040
pmc: PMC6515166
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Department of Health
ID : 11/100/76
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800648
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K015346/1
Pays : United Kingdom
Organisme : Department of Health
ID : TRF-2018-11-ST2-002
Pays : United Kingdom

Références

Ann Rheum Dis. 2001 Mar;60(3):187-93
pubmed: 11171676
J Immunol. 2003 Feb 15;170(4):1854-61
pubmed: 12574351
N Engl J Med. 2004 Jun 17;350(25):2572-81
pubmed: 15201414
Clin Chem Lab Med. 2006;44(5):672-4
pubmed: 16681444
J Clin Rheumatol. 2004 Feb;10(1):28-32
pubmed: 17043458
Inflamm Res. 2007 Jun;56(6):230-9
pubmed: 17607547
Arthritis Rheum. 2008 Mar;58(3):678-88
pubmed: 18311806
Nat Rev Immunol. 2008 Jun;8(6):478-86
pubmed: 18483499
Arthritis Res Ther. 2008;10(5):R105
pubmed: 18761748
J Immunol. 2009 Jan 1;182(1):647-56
pubmed: 19109198
PLoS Med. 2009 Jan 13;6(1):e1
pubmed: 19143467
Am J Pathol. 2009 Apr;174(4):1426-34
pubmed: 19264900
J Allergy Clin Immunol. 2009 May;123(5):1142-9, 1149.e1-5
pubmed: 19275959
Blood. 2010 Apr 8;115(14):2810-7
pubmed: 20101023
Arthritis Rheum. 2010 Apr;62(4):952-9
pubmed: 20131259
Ann Rheum Dis. 2011 Nov;70(11):2022-8
pubmed: 21742639
Arthritis Rheum. 2012 Jan;64(1):99-109
pubmed: 21968742
Nat Immunol. 2011 Oct 19;12(11):1035-44
pubmed: 22012443
N Engl J Med. 2011 Dec 8;365(23):2205-19
pubmed: 22150039
Nat Rev Rheumatol. 2012 Jan 31;8(3):144-52
pubmed: 22293763
J Clin Invest. 2012 May;122(5):1791-802
pubmed: 22505457
Nat Med. 2012 May 04;18(5):693-704
pubmed: 22561833
Arthritis Rheum. 2013 Jan;65(1):109-19
pubmed: 23055095
Curr Opin Rheumatol. 2013 May;25(3):334-44
pubmed: 23492740
Eur J Immunol. 2013 Jul;43(7):1758-68
pubmed: 23595723
Adv Immunol. 2014;122:211-52
pubmed: 24507159
Ann Rheum Dis. 2015 Jul;74(7):1425-31
pubmed: 24618262
Blood. 2014 Apr 24;123(17):e58-67
pubmed: 24671954
Immunity. 2014 Apr 17;40(4):530-41
pubmed: 24726878
Ann Rheum Dis. 2015 Oct;74(10):1915-23
pubmed: 24818634
Chem Immunol Allergy. 2014;100:172-92
pubmed: 24925398
Curr Opin Pharmacol. 2014 Aug;17:45-57
pubmed: 25063971
Eur J Immunol. 2014 Oct;44(10):3045-55
pubmed: 25070188
J Immunol. 2014 Nov 1;193(9):4568-79
pubmed: 25267976
J Intern Med. 2015 Feb;277(2):178-187
pubmed: 25311948
Arthritis Rheumatol. 2015 Apr;67(4):903-13
pubmed: 25510234
J Clin Invest. 2015 Jun;125(6):2317-34
pubmed: 25915587
Eur J Pharmacol. 2016 May 5;778:146-51
pubmed: 25941082
Eur J Pharmacol. 2016 May 5;778:116-24
pubmed: 25943290
Arthritis Rheumatol. 2015 Sep;67(9):2343-53
pubmed: 25989191
J Cell Biol. 2015 Aug 31;210(5):851-64
pubmed: 26304724
Clin Exp Allergy. 2016 Feb;46(2):194-263
pubmed: 26567481
Arthritis Rheumatol. 2016 Mar;68(3):769
pubmed: 26606740
Osteoarthritis Cartilage. 2016 Apr;24(4):664-71
pubmed: 26671522
Blood. 2016 Jan 28;127(4):373-4
pubmed: 26823506
Eur J Immunol. 2016 May;46(5):1132-41
pubmed: 26860071
Arthritis Rheumatol. 2016 Mar;68(3):769-70
pubmed: 26913844
Arthritis Res Ther. 2016 Mar 31;18:74
pubmed: 27036513
Nat Immunol. 2016 Jul;17(7):878-87
pubmed: 27135604
Lancet. 2016 Oct 22;388(10055):2023-2038
pubmed: 27156434
Arthritis Res Ther. 2016 Jun 13;18(1):138
pubmed: 27296719
Exp Dermatol. 2017 Jan;26(1):11-17
pubmed: 27305467
Oncoimmunology. 2016 Mar 30;5(6):e1168556
pubmed: 27471646
J Immunol. 2016 Dec 1;197(11):4473-4481
pubmed: 27799306
Clin Mol Allergy. 2016 Nov 1;14:15
pubmed: 27822141
Transl Med UniSa. 2016 Nov 01;15:34-41
pubmed: 27896225
Int Arch Allergy Immunol. 2016;171(3-4):158-165
pubmed: 27960171
Allergol Int. 2017 Sep;66S:S9-S20
pubmed: 28366675
Autoimmun Rev. 2017 Jun;16(6):557-563
pubmed: 28411167
Lancet. 2017 Jun 10;389(10086):2328-2337
pubmed: 28612747
Lancet. 2017 Jun 10;389(10086):2338-2348
pubmed: 28612748
J Allergy Clin Immunol. 2018 Jan;141(1):311-321.e10
pubmed: 28624612
Front Med (Lausanne). 2017 Jul 24;4:103
pubmed: 28791287
J Exp Med. 2017 Sep 4;214(9):2491-2506
pubmed: 28811324
Autoimmun Rev. 2017 Nov;16(11):1096-1102
pubmed: 28899798
Curr Med Chem. 2018 Feb 09;:null
pubmed: 29424301
Ann Rheum Dis. 2018 Dec;77(12):1773-1781
pubmed: 30127058
J Clin Invest. 2019 Mar 1;129(3):1094-1108
pubmed: 30561384
Ann Rheum Dis. 2019 Jun;78(6):761-772
pubmed: 30878974
Arthritis Rheum. 1987 Feb;30(2):130-7
pubmed: 3548731
Arthritis Rheum. 1984 Aug;27(8):852-6
pubmed: 6380504
Arthritis Rheum. 1984 Aug;27(8):845-51
pubmed: 6466393
Ann Rheum Dis. 1995 Jul;54(7):549-55
pubmed: 7668897
Arthritis Rheum. 1996 Jul;39(7):1222-33
pubmed: 8670335
Arthritis Rheum. 1997 Mar;40(3):469-78
pubmed: 9082935
Arthritis Rheum. 1997 Mar;40(3):479-89
pubmed: 9082936
Clin Sci (Lond). 1997 Oct;93(4):363-70
pubmed: 9404229
J Immunol. 1998 Sep 1;161(5):2586-93
pubmed: 9725260
Ann Rheum Dis. 1998 Nov;57(11):664-71
pubmed: 9924208

Auteurs

Felice Rivellese (F)

William Harvey Research Institute and Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK. rivelles@gmail.com.

Francesca Wanda Rossi (FW)

Department of Translational Medical Sciences (DiSMeT) and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80131 Naples, Italy. frawrossi@yahoo.it.

Maria Rosaria Galdiero (MR)

Department of Translational Medical Sciences (DiSMeT) and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80131 Naples, Italy. mrgaldiero@libero.it.

Costantino Pitzalis (C)

William Harvey Research Institute and Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK. c.pitzalis@qmul.ac.uk.

Amato de Paulis (A)

Department of Translational Medical Sciences (DiSMeT) and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80131 Naples, Italy. depaulis@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH